Skip to main content

Advertisement

Log in

4D Parathyroid CT as the Initial Localization Study for Patients with De Novo Primary Hyperparathyroidism

  • Endocrine Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Preoperative localization of parathyroid tumors of primary hyperparathyroidism (pHPT) is required for minimally invasive parathyroidectomy (MIP). Parathyroid four-dimensional computed tomography (4DCT) has mainly been used as an adjunct to other imaging modalities in the remedial setting. 4DCT was evaluated as the initial localization study in de novo patients with pHPT.

Materials and Methods

A total of 87 consecutive patients underwent parathyroidectomy for pHPT from August 2008 to November 2009. 4DCT was introduced as the preferred imaging modality instead of sestamibi with SPECT (SeS) in April 2009. Results of the imaging studies [4DCT, SeS, and ultrasonography (US)], operative and, pathologic findings, and biochemical measurements were evaluated.

Results

In this study, 84% of patients (73 of 87) underwent an US, 59.8% (52 of 87) a SeS, and 38.0% (33 of 87) had a 4DCT. 4DCT had improved sensitivity (85.7%) over SeS (40.4%) and US (48.0%) to localize parathyroid tumors to the correct quadrant of the neck (P < 0.005) as well as to localize (lateralize) the parathyroid lesions to one side of the neck (93.9% for 4DCT vs. 71.2% for US and 61.5% for SeS; P < 0.005). 4DCT correctly predicted multiglandular disease (MGD) in 85.7% (6 of 7) patients, whereas US and SeS were unable to detect MGD in any case. All patients achieved cure based on intraoperative parathyroid hormone (PTH) measurements and normalization of intact PTH and S-Ca during follow-up.

Conclusions

4DCT provides significantly greater sensitivity than SeS and US for precise localization of parathyroid tumors of pHPT. Additionally, it correctly predicted MGD in a majority of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Carling T, Udelsman R. Parathyroid tumors. Curr Treat Options Oncol. 2003;4:319–28.

    Article  PubMed  Google Scholar 

  2. Lavely WC, Goetze S, Friedman KP, Leal JP, Zhang Z, Garret-Mayer E, et al. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy. J Nucl Med. 2007;48:1084–9.

    Article  PubMed  Google Scholar 

  3. Harris B, Bailey D, Roach P, Marshman D, McElduff A, King G. Use of fusion imaging to localize an ectopic thoracic parathyroid adenoma. Ann Thorac Surg. 2006;82:719–21.

    Article  PubMed  Google Scholar 

  4. Mihai R, Simon D, Hellman P. Imaging for primary hyperparathyroidism—an evidence-based analysis. Langenbecks Arch Surg. 2009;394:765–84.

    Article  PubMed  Google Scholar 

  5. Civelek AC, Ozalp E, Donovan P, Udelsman R. Prospective evaluation of delayed technetium-99m sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism. Surgery. 2002;131:149–57.

    Article  PubMed  Google Scholar 

  6. Erbil Y, Barbaros U, Yanik BT, Salmaslioğlu A, Tunaci M, Adalet I, et al. Impact of gland morphology and concomitant thyroid nodules on preoperative localization of parathyroid adenomas. Laryngoscope. 2006;116:580–5.

    Article  PubMed  Google Scholar 

  7. Sukan A, Reyhan M, Aydin M, Yapar AF, Sert Y, Canpolat T, et al. Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging. Ann Nucl Med. 2008;22:123–31.

    Article  PubMed  Google Scholar 

  8. Barczynski M, Golkowski F, Konturek A, Buziak-Bereza M, Cichon S, Hubalewska-Dydejczyk A, et al. Technetium-99m-sestamibi subtraction scintigraphy vs. ultrasonography combined with a rapid parathyroid hormone assay in parathyroid aspirates in preoperative localization of parathyroid adenomas and in directing surgical approach. Clin Endocrinol (Oxf). 2006;65:106–13.

    Article  Google Scholar 

  9. Kettle AG, O’Doherty MJ. Parathyroid imaging: how good is it and how should it be done? Semin Nucl Med. 2006;36:206–11.

    Article  PubMed  Google Scholar 

  10. Berber E, Parikh RT, Ballem N, Garner CN, Milas M, Siperstein AE. Factors contributing to negative parathyroid localization: an analysis of 1000 patients. Surgery. 2008;144:74–9.

    Article  PubMed  Google Scholar 

  11. Rodgers SE, Hunter GJ, Hamberg LM, Schellingerhout D, Doherty DB, Ayers GD, et al. Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery. 2006;140:932–40; discussion 940–1.

    Article  PubMed  Google Scholar 

  12. Mortenson MM, Evans DB, Lee JE, Hunter GJ, Shellingerhout D, Vu T, et al. Parathyroid exploration in the reoperative neck: improved preoperative localization with 4D-computed tomography. J Am Coll Surg. 2008;206:888–95; discussion 895–6.

    Article  PubMed  Google Scholar 

  13. Thomas DL, Bartel T, Menda Y, Howe J, Graham MM, Juweid ME. Single photon emission computed tomography (SPECT) should be routinely performed for the detection of parathyroid abnormalities utilizing technetium-99m sestamibi parathyroid scintigraphy. Clin Nucl Med. 2009;34:651–5.

    Article  PubMed  Google Scholar 

  14. Carling T, Udelsman R. Focused approach to parathyroidectomy. World J Surg. 2008;32:1512–7.

    Article  PubMed  Google Scholar 

  15. Carling T, Donovan P, Rinder C, Udelsman R. Minimally invasive parathyroidectomy using cervical block: reasons for conversion to general anesthesia. Arch Surg. 2006;141:401–4; discussion 404.

    Article  PubMed  Google Scholar 

  16. Udelsman R, Osterman F, Sokoll LJ, Drew H, Levine MA, Chan DW. Rapid parathyroid hormone measurement during venous localization. Clin Chim Acta. 2000;295:193–8.

    Article  PubMed  CAS  Google Scholar 

  17. Coakley AJ, Kettle AG, Wells CP, O’Doherty MJ, Collins RE. 99Tcm sestamibi—a new agent for parathyroid imaging. Nucl Med Commun. 1989;10:791–4.

    Article  PubMed  CAS  Google Scholar 

  18. Arbab AS, Koizumi K, Toyama K, Arai T, Araki T. Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells. J Nucl Med. 1998;39:266–71.

    PubMed  CAS  Google Scholar 

  19. O’Doherty M.J, Kettle AG, Wells P, Collins RE, Coakley AJ. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies. J Nucl Med. 1992;33:313–8.

    PubMed  Google Scholar 

  20. Hetrakul N, Civelek AC, Stagg CA, Udelsman R. In vitro accumulation of technetium-99 m-sestamibi in human parathyroid mitochondria. Surgery. 2001;130:1011–8.

    Article  PubMed  CAS  Google Scholar 

  21. Johnston LB, Carroll MJ, Britton KE, Lowe DG, Shand W, Besser GM, et al. The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging. J Clin Endocrinol Metab. 1996;81:346–52.

    Article  PubMed  CAS  Google Scholar 

  22. Politz D, Livingston CD, Victor B, Askew R, Jones L. Minimally invasive radio-guided parathyroidectomy in 152 consecutive patients with primary hyperparathyroidism. Endocr Pract. 2006;12:630–4.

    PubMed  Google Scholar 

  23. Erbil Y, Barbaros U, Tükenmez M, Işsever H, Salmaslioğlu A, Adalet I, et al. Impact of adenoma weight and ectopic location of parathyroid adenoma on localization study results. World J Surg. 2008;32:566–71.

    Article  PubMed  Google Scholar 

  24. Kebapci M, Entok E, Kebapci N, Adapinar B. Preoperative evaluation of parathyroid lesions in patients with concomitant thyroid disease: role of high resolution ultrasonography and dual phase technetium 99m sestamibi scintigraphy. J Endocrinol Invest. 2004;27:24–30.

    PubMed  CAS  Google Scholar 

  25. Gilat H, Cohen M, Feinmesser R, Benzion J, Shvero J, Segal K, et al. Minimally invasive procedure for resection of a parathyroid adenoma: the role of preoperative high-resolution ultrasonography. J Clin Ultrasound. 2005;33:283–7.

    Article  PubMed  Google Scholar 

  26. Melton GB, Somervell H, Friedman KP, Zeiger MA, Cahid Civelek A. Interpretation of 99mTc sestamibi parathyroid SPECT scan is improved when read by the surgeon and nuclear medicine physician together. Nucl Med Commun. 2005;26:633–8.

    Article  PubMed  Google Scholar 

  27. Leswick DA, Hunt MM, Webster ST, Fladeland DA. Thyroid shields versus z-axis automatic tube current modulation for dose reduction at neck CT. Radiology. 2008;249:572–80.

    Article  PubMed  Google Scholar 

  28. Pappu S, Donovan P, Cheng D, Udelsman R. Sestamibi scans are not all created equally. Arch Surg. 2005;140:383–6.

    Article  PubMed  Google Scholar 

  29. Siperstein A, Berber E, Mackey R, Alghoul M, Wagner K, Milas M. Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism. Surgery. 2004;136:872–80.

    Article  PubMed  Google Scholar 

  30. Ho Shon IA, Yan W, Roach PJ, Bernard EJ, Shields M, Sywak M, et al. Comparison of pinhole and SPECT 99mTc-MIBI imaging in primary hyperparathyroidism. Nucl Med Commun. 2008;29:949–55.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tobias Carling MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Starker, L.F., Mahajan, A., Björklund, P. et al. 4D Parathyroid CT as the Initial Localization Study for Patients with De Novo Primary Hyperparathyroidism. Ann Surg Oncol 18, 1723–1728 (2011). https://doi.org/10.1245/s10434-010-1507-0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-010-1507-0

Keywords

Navigation